ACADIA Pharmaceuticals, Inc. (ACAD)
19.95
+0.06
(+0.30%)
USD |
NASDAQ |
Oct 02, 16:00
19.96
+0.01
(+0.05%)
After-Hours: 20:00
ACADIA Pharmaceuticals Price : 19.95 for Oct. 2, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 02, 2026 | 20.01 | 20.24 | 19.88 | 19.95 | 2.565M |
| Oct 01, 2026 | 19.95 | 20.19 | 19.59 | 19.89 | 2.732M |
| Sep 30, 2026 | 20.28 | 20.70 | 19.93 | 20.15 | 3.134M |
| Sep 29, 2026 | 20.60 | 20.60 | 20.06 | 20.22 | 2.515M |
| Sep 28, 2026 | 20.53 | 20.63 | 19.80 | 20.53 | 3.523M |
| Sep 25, 2026 | 22.21 | 22.21 | 20.61 | 20.68 | 3.364M |
| Sep 24, 2026 | 24.38 | 24.38 | 21.97 | 22.18 | 6.762M |
| Sep 23, 2026 | 26.41 | 26.51 | 24.93 | 25.43 | 1.306M |
| Sep 22, 2026 | 26.65 | 26.86 | 26.32 | 26.41 | 1.472M |
| Sep 21, 2026 | 27.43 | 27.43 | 26.34 | 26.40 | 1.352M |
| Sep 18, 2026 | 27.37 | 27.48 | 26.73 | 27.29 | 5.483M |
| Sep 17, 2026 | 27.78 | 28.06 | 27.29 | 27.45 | 1.308M |
| Sep 16, 2026 | 26.75 | 27.60 | 26.66 | 27.54 | 1.405M |
| Sep 15, 2026 | 27.51 | 27.51 | 26.64 | 26.76 | 1.109M |
| Sep 14, 2026 | 28.00 | 28.10 | 27.38 | 27.52 | 1.629M |
| Sep 11, 2026 | 27.98 | 28.24 | 27.74 | 27.83 | 1.173M |
| Sep 10, 2026 | 27.63 | 27.86 | 27.36 | 27.74 | 1.015M |
| Sep 09, 2026 | 27.44 | 27.95 | 27.40 | 27.68 | 1.294M |
| Sep 08, 2026 | 27.63 | 28.09 | 27.10 | 27.58 | 1.458M |
| Sep 04, 2026 | 27.77 | 28.19 | 27.65 | 28.02 | 1.683M |
| Sep 03, 2026 | 29.00 | 29.06 | 27.62 | 27.86 | 1.849M |
| Sep 02, 2026 | 29.10 | 29.75 | 28.88 | 28.93 | 1.556M |
| Sep 01, 2026 | 28.84 | 29.30 | 28.51 | 28.89 | 830929.0 |
| Aug 31, 2026 | 29.05 | 29.12 | 28.58 | 28.91 | 1.036M |
| Aug 28, 2026 | 29.51 | 29.72 | 29.02 | 29.11 | 1.530M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Agios Pharmaceuticals, Inc. | 31.80 |
| Biogen, Inc. | 219.88 |
| Insmed, Inc. | 111.12 |
| Arcutis Biotherapeutics, Inc. | 25.16 |
| BioMarin Pharmaceutical, Inc. | 57.18 |
Price Related Metrics
| PE Ratio | 8.985 |
| PS Ratio | 3.012 |
| PEG Ratio | 0.1344 |
| Price to Book Value | 2.628 |
| Price to Free Cash Flow | 23.55 |
| Earnings Yield | 11.13% |
| Market Cap | 3.434B |
| PEGY Ratio | 0.1344 |
| Operating PE Ratio | 39.71 |
| Normalized PE Ratio | 8.985 |